AstraZeneca

Stories 21 - 40 | << Prev   Next >>

EU Backs AstraZeneca Vaccine, With an Asterisk

Medical agency cannot 'definitively' rule out a link to clots, but says benefits outweigh risks

(Newser) - The EU's medical agency made clear on Thursday that it wants nations to continue doling shots of the AstraZeneca vaccine . But it added a caveat that could give ammunition to the dozen or so European nations that have suspended its use:
  • Bottom line: “Our scientific position is
...

EU Agency Is Conducting New Review of Vaccine

Several nations have paused AstraZeneca version over concerns about clots

(Newser) - Controversy over the AstraZeneca vaccine is putting Europe further behind schedule on vaccinations. The goal is to inoculate 70% of the population by September, and no EU nation is on track to meet that deadline, reports the New York Times . Germany, Spain, France, and Italy are among the nations that...

Germany, France, Italy Suspend Use of AstraZeneca Vaccine

They're investigating reports of blood clots

(Newser) - Germany, France, and Italy on Monday became the latest countries to suspend use of AstraZeneca's COVID-19 vaccine over reports of dangerous blood clots in some recipients, though the company and European regulators have said there is no evidence the shot is to blame. Germany's health minister said the...

AstraZeneca Defends Its Vaccine
AstraZeneca
Defends
Its Vaccine
Mar 15, 2021 7:04 AM CDT

AstraZeneca Defends Its Vaccine

More countries suspend use over concern about blood clots

(Newser) - AstraZeneca is defending its COVID vaccine after more countries suspended its use over health concerns . The company said Sunday night that its own review of more than 17 million inoculations found no increased risk of blood clots, reports Reuters . Major health agencies including the World Health Organization and European Medicines...

US Has Unused Vaccine, and Europe Wants It

US, which hasn't yet approved AstraZeneca vaccine, has tens of millions of doses that other nations want now

(Newser) - There's no approval yet for the Oxford-AstraZeneca vaccine in the States, but in many countries there is—and those countries are miffed that in the meantime, the US is hoarding tens of millions of doses that could be getting injected into arms overseas. On Thursday, European Union sources told...

2 Die of Blood Clots After Vaccine Dose

Both doses came from batch ABV5300 of the Oxford-AstraZeneca vaccine

(Newser) - Denmark is suspending use of the Oxford-AstraZeneca vaccine for 14 days from Thursday following reports of "severe cases of blood clots." Health Minister Magnus Heunicke stresses the move is a "precautionary measure" as the fatal or life-threatening blood clots reported in a handful of vaccine recipients have...

Italy Keeps AstraZeneca Doses Bound for Australia

Country says company has failed to meet its commitments to bloc

(Newser) - Italy, which has recorded 428,500 new COVID cases and almost 10,000 deaths over the last month, has balked at exporting doses of AstraZeneca vaccine to Australia, which has recorded 190 cases and zero deaths in the same time period. Italy has blocked a shipment to Australia of 250,...

World's Largest Vaccine Operation in History Begins

Ghana is first nation in world to receive COVID vaccines through the COVAX initiative

(Newser) - Ghana has become the first country in the world to receive vaccines acquired through the United Nations-backed COVAX initiative with a delivery of 600,000 doses of the AstraZeneca vaccine made by the Serum Institute of India. The vaccines, delivered by UNICEF, arrived at Accra’s international airport early Wednesday...

WHO Grants Emergency Authorization to Vaccine

Hundreds of millions of AstraZeneca doses will be shipped to countries in COVAX program

(Newser) - The World Health Organization has granted an emergency authorization to AstraZeneca's coronavirus vaccine, a move that should allow the UN agency's partners to ship millions of doses to countries worldwide as part of a UN-backed program to tame the pandemic. In a statement Monday, the WHO said it...

Vaccine Brand Is Tough Sell in Europe

Experts say comparisons of the products' efficacy can be misleading

(Newser) - Many Europeans are desperate for a coronavirus vaccine. But not just any vaccine. As AstraZeneca shots are rolling out to European Union nations this month, joining the Pfizer and Moderna doses already available, some people are balking at being offered a vaccine that they perceive—fairly or not—as second-best....

Oxford Vaccine Headed for Kids' Arms

Young volunteers being sought for Oxford/AstraZeneca vaccine testing

(Newser) - The University of Oxford plans to test its COVID-19 vaccine in children for the first time, becoming the latest vaccine developer to assess whether its coronavirus shot is effective in young people. The trial announced Saturday seeks to recruit 300 volunteers between the ages of 6 and 17, with up...

One Country Forced to Stop AstraZeneca Vaccine Rollout

After study shows disappointing results against new strain in South Africa

(Newser) - South Africa has put its rollout of AstraZeneca's COVID-19 vaccine, originally due to start next week, on hold after a study found it offered only minimal protection against a new variant of the coronavirus currently dominating new infections in the country. The study found that the vaccine "does...

Mixing Vaccines Could Provide &#39;Better Antibody Response&#39;
New Study Looks
at Mixing Vaccines
Feb 4, 2021 8:27 AM CST

New Study Looks at Mixing Vaccines

Human trial will attempt to replicate results found in mice

(Newser) - There have been limited cases of people receiving one coronavirus vaccine for their first dose, and a different vaccine for their second. So how will that affect their immunity? That's now the subject of a trial in the UK, seeking to discover whether a mix of vaccines proves effective...

New AstraZeneca Vaccine Stats Are &#39;Absolutely Superb&#39;
New AstraZeneca Vaccine
Stats Are 'Absolutely Superb'
new research
Feb 3, 2021 10:35 AM CST

New AstraZeneca Vaccine Stats Are 'Absolutely Superb'

2-dose vaccine has high efficacy after one dose

(Newser) - With the rollout of each coronavirus vaccine comes a big focus on efficacy, and new research on the Oxford-AstraZeneca version gets much more granular. In a study that has yet to be peer-reviewed, University of Oxford researchers found the two-dose vaccine was 76% effective at preventing symptomatic infections for three...

UK Takes Another 'Giant Step' on Vaccine Front

Britain is now administering the world's first AstraZeneca-Oxford COVID vaccinations

(Newser) - Britain on Monday took another giant step in the fight against COVID-19, ramping up its immunization program by giving the first shots in the world from the vaccine created by Oxford University and pharmaceutical giant AstraZeneca. Dialysis patient Brian Pinker, 82, was the first to get the new vaccine, administered...

2nd Vaccine OK'd in UK Is Cheaper, Easier to Store

AstraZeneca/Oxford shots will start to be administered in Britain next week

(Newser) - A big update in vaccination efforts from across the pond: In what Prime Minister Boris Johnson is calling a "triumph for British science," regulators in the United Kingdom have given the green light to a second vaccine there, this time for one from AstraZeneca and Oxford University. Why...

AstraZeneca Has Confidence About New Strain

CEO says his vaccine will be as good as the others

(Newser) - The head of drugmaker AstraZeneca, which is developing a coronavirus vaccine widely expected to be approved by UK authorities this week, said Sunday that researchers believe the shot will be effective against a new variant of the virus driving a rapid surge in infections in Britain. Partial results suggest that...

As UK Begins Shots, Progress on US Front

Pfizer candidate clears hurdle ahead of crucial Thursday meeting

(Newser) - It's a big news day for COVID vaccines on three fronts:
  • The UK began its first vaccinations .
  • In the US, health regulators say in their initial review that Pfizer's vaccine is 95% protective, per the AP . The review posted online Tuesday by the FDA comes before a Thursday
...

After AstraZeneca's Big Vaccine Claim, Questions

90% efficacy was seen in participants given a half-dose by accident

(Newser) - Initial results regarding the AstraZeneca and University of Oxford COVID-19 vaccine had the industry buzzing Monday—but that enthusiasm is beginning to erode. The vaccine was said to be up to 90% effective , quite cheap at $3 to $5 per dose , and able to be stored for months in a...

Organization Questions 'No-Profit' Promise on Vaccine

AstraZeneca cuts deals with governments, partners around the world

(Newser) - AstraZeneca could not have bigger plans for its coronavirus vaccine. The company intends to make its vaccine available in every part of the world and expects to produce 3 billion doses to make that possible. The vaccine, developed by Oxford University, could turn out to be more practical, easier to...

Stories 21 - 40 | << Prev   Next >>
Most Read on Newser